EUVIMEDEUVIMED entdecken
Multizentrische Studie

Deciphering the significance of tumor necrosis and developing a grading system in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study

Han Wang, You-Wen Qian, Xia Sheng, Chun-Yan Xia, Hong-Zhen Chen, Zhen-Yu Cao, Hua Yu, Ying-Ying Zhou, Wen-Ming Cong, Miao-Xia He, Hui Dong

Pathology - Research and Practice · 2026

DOI: 10.1016/j.prp.2025.156335 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Pathology - Research and Practice, 2026. Verfasst von Han Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Yangpu, Shanghai 200438, China; Department of Pathology, C…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Liver Neoplasms, Carcinoma, Hepatocellular, Bile Duct Neoplasms. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Naval Medical University, National Health Commission of the People's Republic of China, Shanghai Municipality Science and Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Combined hepatocellular-cholangiocarcinoma (cHCC-CCA) lacks standardized pathological diagnostic paradigm. The significance of tumor necrosis in cHCC-CCA remains undefined. This study aimed to decipher its role and develop a practical grading system. METHODS: A multicenter analysis was conducted on 307 cHCC-CCA patients. Tumor necrosis was pathologically graded as: TN1 (no necrosis, N = 35), TN2 (focal necrosis; maximum diameter of a single focus ≤0.55 cm/one low-power field, N = 129), and TN3 (extensive necrosis; >0.55 cm, N = 143). Associations between tumor necrosis and clinicopathological features, recurrence-free survival (RFS), overall survival (OS), early RFS (≤2 years), and late RFS (>2 years) were assessed. The impact of postoperative adjuvant transarterial chemoembolization (PA-TACE) was also evaluated. RESULTS: Higher necrosis grades (TN2/TN3) were significantly associated with aggressive tumor characteristics, including larger tumor size, vascular invasion, and lymph node metastasis. TN3 patients had the worst median RFS (0.28 years) and OS (1.36 years), compared to TN2 (RFS: 0.68 years; OS: 2.64 years) and TN1 (RFS: 1.46 years; OS: not reached). The grading system was an independent prognostic factor for RFS, OS, and early RFS in multivariate analysis. PA-TACE significantly improved early RFS in the TN2/TN3 groups and RFS in the TN3 group specifically, but not in the TN1 group. CONCLUSIONS: Tumor necrosis in cHCC-CCA indicates aggressive tumor biology and poorer outcomes. The proposed three-tier grading system provides robust prognostic stratification. PA-TACE benefits patients with significant necrosis (TN2/TN3), particularly in preventing early recurrence. Standardized assessment of tumor necrosis is recommended to optimize risk stratification and guide adjuvant therapy decisions for cHCC-CCA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaLiver NeoplasmsCarcinoma, HepatocellularBile Duct NeoplasmsHumansMaleFemaleNecrosisMiddle AgedAgedNeoplasm GradingAdultChemoembolization, TherapeuticPrognosis

Stichwörter der Autor:innen

Combined hepatocellular-cholangiocarcinomaMixed hepatocellular-cholangiocarcinomaPathological assessmentPostoperative adjuvant transarterial chemoembolizationTumor necrosisTumoral necrosis

Autor:innen und Institutionen

  • Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Yangpu, Shanghai 200438, China; Department of Pathology, Changhai Hospital, Naval Medical University, Yangpu, Shanghai 200433, C…
  • Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Yangpu, Shanghai 200438, China.
  • Department of Pathology, Minhang Hospital, Fudan University, Minhang, Shanghai 201199, China.
  • Department of Pathology, Changzheng Hospital, Naval Medical University, Huangpu, Shanghai 200003, China.
  • Department of Pathology, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Gongshu, Hangzhou 310000, China.
  • Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Naval Medical University, Yangpu, Shanghai 200438, China. Electronic address: wmcong@smmu.edu.cn.

Förderung

  • Naval Medical University
  • National Health Commission of the People's Republic of China
  • Shanghai Municipality Science and Technology Commission
  • Shanghai Shenkang Hospital Development Center

Zitieren

APA

Wang, H., Qian, Y. W., Sheng, X., Xia, C. Y., Chen, H. Z., Cao, Z. Y., Yu, H., Zhou, Y. Y., Cong, W. M., He, M. X., & Dong, H. (2026). Deciphering the significance of tumor necrosis and developing a grading system in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156335

Vancouver

Wang H, Qian YW, Sheng X, Xia CY, Chen HZ, Cao ZY, et al. Deciphering the significance of tumor necrosis and developing a grading system in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study. Pathology - Research and Practice. 2026. doi:10.1016/j.prp.2025.156335

BibTeX
@article{Wang2026,
  author = {Wang, Han and Qian, You-Wen and Sheng, Xia and Xia, Chun-Yan and Chen, Hong-Zhen and Cao, Zhen-Yu and Yu, Hua and Zhou, Ying-Ying and Cong, Wen-Ming and He, Miao-Xia and Dong, Hui},
  title = {Deciphering the significance of tumor necrosis and developing a grading system in combined hepatocellular-cholangiocarcinoma: A multicenter pathological study},
  journal = {Pathology - Research and Practice},
  year = {2026},
  doi = {10.1016/j.prp.2025.156335}
}
Kostenlos starten →